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Introduction 
Since 2005, the Italian National Health System (NHS) has 
implemented a screening program for colorectal cancer for all 
citizens over 50. Screening tests are free for the target 
population (so-called Minimal Care Level guaranteed for all 
Italian citizens). Invitees are asked to take an immunological 
test for Faecal Occult Blood (FOBT) every two years. 
Individuals with a positive FOBT test are invited to undergo a 
total colonoscopy in an SSN-accredited Endoscopy 
Department. 
Each Italian Region has a centre for the coordination of the 
screening programme, which employs a dedicated software that 
can trace the progress of each citizen within the programme: 
•  FOBT invitation (first round) compliance/non-
compliance (reminder); 
•  FOBT positive cases: total colonoscopy, endoscopic or 
surgical treatment of screen-detected lesions plus 
follow-up; 
•  FOBT negative cases: FOBT invitation after two years 
(second round). 
The ‘Screening Centre’ has a database that can provide a 
detailed, real-time status of the programme: it is therefore 
possible to compare the characteristics of screen-detected and 
non-screen-detected cancers. 
The target population for the screening programme includes all 
citizens aged 50–70, except ‘high-risk’ subjects (family history; 
serious, persistent IBD; previous colorectal surgery; recent non-
screen-related FOBT and/or colonoscopy; apparent digestive-
tract symptoms (proctorrhagia, abdominal pain, bowel 
irregularities, etc)). 
 
Screen-detected lesions 
Table 1 reports the results of the screening programme for 2006 
and 2007, as registered at the Lombardy Screening Centre 
(9,500,000 inhabitants, 2,481,117 of whom make up the target 
population). Table 2 reports the results of the same screening 
programme in Milan (1,300,000 inhabitants, 323,976 of whom 
make up the target population). In both tables, detection-rate 
data for FOBT positive subjects who underwent total 
colonoscopy are shown in bold type: in 2006, in Lombardy, 721
carcinomas and 3369 ‘high-risk’ polyps were detected in 
asymptomatic patients, out of 12,293 total colonoscopies (PPV 
in colonoscopy after FOBT positive: 7.3 + 34 = 41.3%). 
After completing the first round of the programme (all citizens of 
Milan were invited to undergo FOBT through a letter, followed 
by reminders to non-compliant subjects), in Milan, 327 
carcinomas and 1370 ‘high-risk’ polyps were detected in 
asymptomatic patients out of 4907 total colonoscopies (PPV in 
colonoscopy after FOBT positive: 8 + 33.5 = 41.5%). 
Programme DR for carcinoma: 3.17%, Programme DR for ‘high 
risk’ polyps: 13.27%. 
 
Non-screen-detected lesions 
Through the NHS archives, it was possible to analyse workload 
and results of colorectal-cancer treatment in clinical practice 
(‘symptomatic’ patients) over the same period of time as the 
NHS-activated screening. 
 
Screen-detected and non-screen-detected 
tumours treated at IEO (2006–8) 
Table 3 shows colorectal-cancer cases treated at the European 
Institute of Oncology (a cancer centre in Milan that is one of the 
nine SSN-accredited endoscopy units for the screening 
programme, as well as a general surgery unit). Between 
January 2006 and August 2008, 503 operations for colorectal 
cancer were performed, 228 of which were carried out on 
patients, aged 50–69, from Lombardy. Of these 228 operations, 
106 cases (45%) were screen detected and 38 of which (35.8%) 
for cancerous polyps. Over the same period, 122 operations 
were performed for non-screen-detected cancers (53% of the 
total), 14 of which (11.4%) for cancerous polyps. 
Surgical radicalization (resection plus lymphadenectomy) after 
‘complete’ endoscopic polypectomy was performed in 39 
patients (27 screen detected and 12 non-screen detected). 
 
Discussion 
Screen-detected tumours have a more favourable staging than 
non-screen-detected lesions, as demonstrated in Table 3, with a 
significantly lower incidence of pT3-4, pN+, M+ cases. 
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Table 1: Regional screening programme (Lombardy) 2005–7 
 
 
Table 2: Milan Screening Programme—results after first FOBT round (2006–8) 
Cancerous polyps are 35.8% of screen-detected carcinomas 
and only 11.4% of non-screen detected tumours. 
During the first screening round (2006–7), colorectal-cancer 
incidence increased both in Lombardy and in Milan, as reported 
in the corresponding Tumour Registry. This increase is due to 
the diagnosis of colorectal cancer in asymptomatic subjects. 
Through tumour registries it will be possible to evaluate whether 
there is a future incidence decrease (which is probable, 
considering that during the screening ‘high-risk’ polyps are 
diagnosed and removed, that is definitely pre-cancer lesions). 
Because of the screening programme, it is more often possible 
to detect lesions that were rare during the pre-screening era. In 
particular, a large number of ‘cancerous’ and ‘high-risk’ polyps 
are detected and treated. This has led to better knowledge of 
these lesions. 
Figures 1–8 show histopathological characteristics of cancerous 
polyps at ‘low’ and ‘high risks’ for nodal metastases. Because of 
the everyday incidence of these ‘early-stage’ carcinomas, the 
screening programme led to an improvement in both 
endoscopic and pathological diagnoses, with a better evaluation
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Table 3: IEO surgical treatment in screen-detected versus non-screen-detected colorectal cancer (from January 2006 to August 2008) 
 
 
 
Figure 1: Pathological aspect of a malignant polyp.
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Figure 2: Histology—malignant polyp with mucinous aspects. 
 
 
Figure 3: Grading—low-grade malignant polyp (G2).
of these lesions by endoscopists, pathologists and surgeons 
who have to manage, with the patient, their ‘clinical risk’. 
Endoscopists from screening-accredited centres must acquire 
great expertise in treating lesions detected in FOBT positive 
subjects.  Videos 1–3 show some endoscopic procedures 
performed for screen-detected lesions by the Division of 
Endoscopy of the European Institute of Oncology. 
As for the already well-established screening programmes for 
breast and cervical cancers, Italian experts from different areas 
created the Italian Group for Colorectal Cancer Screening 
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Figure 4: Grading—high-grade malignant polyp (G3). 
 
(a) 
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(b) 
 
 
(c) 
 
Figure 5: Vascular invasion (a–c).
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(a) 
 
(b) 
 
Figure 6: (a) Budding; (b) Low-grade budding.
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Figure 7: Microstaging—infiltration width and depth. 
 
Figure 8: Positive margins.
(Gruppo Italiano Screening ColoRettale—GISCoR), which 
promotes and quality-controls screening programmes all over 
Italy. 
Through the assessment of screen-detected lesions, it will be 
possible to understand whether screening only offers ‘earlier 
diagnosis’ or if there are real ‘biological differences’ between 
screen- and non-screen-detected tumours. Through the 
establishment of a tissue bank of carefully collected specimens 
from all the screening centres, any differences can be analysed 
by clinical and translational studies comparing screen-detected 
and non-screen-detected cancers. 
As Italian screening programmes are still new, the follow-up of 
identified lesions is still too recent to allow a comparison on 
survival (either overall or disease free) and mortality (either 
disease related or non-disease related). Significant data 
regarding follow-up of both screen-detected and non- 
screen-detected tumours will be available in a few years' 
time. 
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To view this video click here: 
 
http://www.ecancermedicalscience.com/view-article.asp?doi=10.3332/ecancer.2009.142
Video 1: 20 mm flat lesion of the caecum. Chromoendoscopy with indigo carmine shows glandular pattern typical for neoplastic adenomatous 
flat lesions. 
To view this video click here: 
 
http://www.ecancermedicalscience.com/view-article.asp?doi=10.3332/ecancer.2009.142
Video 2: The lesion described above is removed by single-piece mucosectomy after submucosal injection of saline to elevate the flat lesion 
To view this video click here: 
 
http://www.ecancermedicalscience.com/view-article.asp?doi=10.3332/ecancer.2009.142
Video 3: Endoloop-assisted polypectomy to prevent bleeding for a 4-cm peduncolated adenoma with a broad stalk. 
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